-
Indegene IPO: Demystifying Complex Business
Pharma companies have expertise in developing drugs and distributing them. However, they might lack the required competency in AI (Artificial Intellig
-
SIP registrations rising, so are closures
More SIPs being discontinued; Bombay HC stays RBI’s ‘fraud’ ruling; Coal India stock available at over Re 1 discount; E2W sales plunge 62% after
-
Insiders selling on fast lane as Sensex hits all-time high
Edelweiss Alternative Research showed that insiders from select banks, FMCG, chemical, pharma and real estate sold some of their shares in July
-
Markets not done with correction, will wait for deeper fall to buy: Vinit Bolinjkar
With the heightened activity in the IPO space, there could be some more subdued action in the secondary markets going forward
-
After Covid, PLI set to be next big trigger for pharma cos
Production linked incentive scheme is likely to add approximately 15% to the current market size of the pharma market once fully implemented
-
Stock market update: Sensex, Nifty pare some losses; pharma shares rally
The IPOs of Krishna Institute and Dodla Dairy opened for subscription on Wednesday (June 16) and will close today (June 18).
-
Centre gives approval to four firms under PLI scheme for bulk drugs
The companies which have been given approval are -- Solara Active Pharma Science Ltd, Rajasthan Antibiotics Ltd, Dhatri Lab Pvt Ltd and Vital Labo
-
Markets shrug Covid concerns on Monday. Here’s what investors should do today
COVID-19 updates, earnings and IIP, CPI data will steer the stock markets in the truncated week
-
How to tweak your investment portfolio amid the expanded vaccination drive?
Chasing the stocks which have already run up too much, might not be wise
-
Prime Minister Narendra Modi asks pharma cos to maintain smooth supply of Covid-19 medicines
Modi said it is because of the efforts of the pharma industry that today India is identified as ‘pharmacy of world’
